5% stakes
Sirenia Capital Management
Institution
- 5% stake reports
- 27
- 5% stake stocks
- 20
- Latest report
- 26/08/14
5% stake reports
| Stock | ||
|---|---|---|
| Traws Pharma TRAW08/14 | 9.9%6,565,474 sh | First report |
| Tonix Pharmaceuticals Holding TNXP08/14 | 4.9%814,801 sh | −3.9pp |
| Q32 Bio QTTB08/14 | 0%0 sh | −9.9pp |
| InflaRx IFRX08/14 | 6.1%8,911,348 sh | First report |
| Immunome IMNM08/14 | 4.3%4,832,279 sh | −1.8pp |
| First Tracks Biotherapeutics TRAX08/14 | 7.2%2,495,777 sh | First report |
| Dianthus Therapeutics DNTH08/14 | 3.1%1,696,751 sh | −2.2pp |
| Design Therapeutics DSGN08/14 | 9.5%5,963,936 sh | First report |
| Cybin HELP08/14 | 4.8%3,029,500 sh | −2.4pp |
| Anaptysbio ANAB08/14 | 5%1,491,959 sh | −1.7pp |
| Alto Neuroscience ANRO08/14 | 6.2%2,219,568 sh | −1.7pp |
| Immunome IMNM05/15 | 6.1%6,895,000 sh | First report |
| iBio05/15 | 9.9%11,586,340 sh | First report |
| Edesa Biotech EDSA05/15 | 7.2%600,000 sh | First report |
| Dianthus Therapeutics DNTH05/15 | 5.3%2,798,122 sh | First report |
| Cybin HELP05/15 | 7.2%3,677,966 sh | First report |
| Corvus Pharmaceuticals CRVS05/15 | 7.5%6,831,828 sh | First report |
| C4 Therapeutics CCCC05/15 | 9.9%23,505,000 sh | First report |
| Anaptysbio ANAB05/15 | 6.7%1,920,402 sh | First report |
| Alto Neuroscience ANRO05/15 | 7.9%2,591,587 sh | First report |
